Confo Therapeutics
1 follower
Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior s... Read more
Org chart
Cedric Ververken
Collapse
Frank Landolt
Chief Counsel, Intellectual Property & Legal
Paolo Vicini
Chief Development Officer
Marc Moens
Head, Finance & HR
Stephanie Staelens
Project Manager, Early Drug Discovery
Stephen Dowd
Chief Business Officer
Andreas Busch
Senior Scientist - Protein Science
Caroline Segers
Senior Research Associate
Richa Virmani
Scientist
Thomas Fontaine
Associate Scientist
Bruno Ranschaert
R&d Application Architect
Geert Degruyter
System Administrator
